График акции Cybin Inc.
Расширенный график
Простой график
О компании
Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in Phase 1/2a clinical trial to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine, which is in Phase 1 clinical trial for treating generalized anxiety disorders; and CYB005, a phenethylamine derivative, which in in preclinical stage to treat neuroinflammation. ПодробнееEBITDA | -8.1E-5 |
---|---|
EV/EBITDA | 3.9 |
IPO date | 2019-09-13 |
ISIN | CA23256X1006 |
Industry | Biotechnology |
P/BV | 1.41 |
P/S | 140.78 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | cad |
Выручка | 0.000864 |
Сайт | https://www.cybin.com |
Цена ао | 8.9 |
Число акций ао | 0.18543 млрд |
Изменение цены за день: | +0.6787% (8.84) |
---|---|
Изменение цены за неделю: | -13.93% (10.34) |
Изменение цены за месяц: | +3 976.96% (0.2183) |
Изменение цены за 3 месяца: | +3 264.84% (0.2645) |
Изменение цены за полгода: | +1 993.63% (0.4251) |
Изменение цены за год: | +1 478.01% (0.564) |
Изменение цены за 3 года: | +283.62% (2.32) |
Изменение цены с начала года: | +1 445.14% (0.576) |
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
Институционалы | Объем | Доля, % |
---|---|---|
Point72 Asset Management, L.P. | 30061112 | 4.04 |
Anson Funds Management LP | 8924494 | 1.2 |
Alyeska Investment Group, L.P. | 5683196 | 0.76 |
CVI Holdings, LLC | 5225262 | 0.7 |
AdvisorShares Investments, LLC | 1859181 | 0.25 |
PDS Planning, Inc | 1153120 | 0.16 |
Propel Bio Management, LLC | 850000 | 0.11 |
Simplify Asset Management, Inc. | 500000 | 0.07 |
FNY Investment Advisers, LLC | 402000 | 0.05 |
Lewis Asset Management, LLC | 282000 | 0.04 |
Руководитель | Должность | Оплата | Год рождения |
---|---|---|---|
Mr. Eric So L.L.B. | Co-Founder, President & Executive Chairman | 458.88k | 1976 (48 лет) |
Mr. Douglas L. Drysdale | Chief Executive Officer | 613.44k | 1970 (54 года) |
Mr. Paul Glavine | Co-Founder, Chief Growth Officer & Director | 458.88k | 1989 (35 лет) |
Mr. Greg Cavers | Chief Financial Officer | 242.09k | 1971 (53 года) |
Mr. Aaron Bartlone | Chief Operating Officer | 379.12k | 1967 (57 лет) |
Mr. John Kanakis | Co-Founder | 704.03k | 1981 (43 года) |
Dr. Alex L. Nivorozhkin Ph.D. | Chief Scientific Officer | N/A | 1960 (64 года) |
Ms. Lori Challenger | Chief Compliance, Ethics & Administrative Officer | N/A | |
Mr. Gabriel Fahel | Chief Legal Officer & Corporate Secretary | N/A | 1976 (48 лет) |
Mr. George Tziras | Chief Business Officer & Director | 1981 (43 года) |
Адрес: Canada, Toronto, 100 King Street West - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.cybin.com
Сайт: https://www.cybin.com